A case report: A new promising treatment for pulmonary sarcomatoid carcinoma - Tislelizumab and Anlotinib combined with local radiotherapy

BACKGROUND: Pulmonary sarcomatoid carcinoma (PSC) is a rare pathological type of non-small cell lung cancer, only occurs in 0.1%–0.4 % of lung cancer patients. It has a poor prognosis and shows low response to conventional chemotherapy. Target therapy, immunotherapy, and other new approaches are wor...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Ruoxue, Liu, Ying, Sha, Huanhuan, Yu, Jingjing, Fang, Ying, Zhou, Guoren, Shen, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10656269/
https://www.ncbi.nlm.nih.gov/pubmed/38027958
http://dx.doi.org/10.1016/j.heliyon.2023.e21902

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10656269/
https://www.ncbi.nlm.nih.gov/pubmed/38027958
http://dx.doi.org/10.1016/j.heliyon.2023.e21902

Ejemplares similares